About the Conference

The Global Summit of Biopharma entitled 'New targets, new modalities and New Hopes' will take place from Wednesday 11 May to Friday 13 May, 2022 in Tokyo, Japan. It provides an intensive comprehensive program focusing on new targets discovery, design of new modalities, cutting-edge technologies, new discovery chemistry, innovative process development, smart bio-drug delivery systems and new biosimilars.

Conference Chairs
Dr. Xiaodan Mei

BIT Group
Dr. John Xu
Keynote Speakers
Prof. Shibo Jiang
Director, Institute of Medical Microbiology, Fudan University, China

Title: R&D of Broad-spectral Antivirals
Dr. Frank Li
Founder and CEO, BLA Regulatory, USA
Program Layout


Program Layout
Plenary Lectures: Opening Ceremony and Keynote Forum
Theme 1
New Drug Targets
Theme 1 will cover current frontiers of emerging targets for bio-drug discovery
Theme 8
New Delivery Systems
Theme 8 will cover current frontiers of innovative DDS for bio-drugs and difficult delivery biotherapies.
Theme 2
New Drug Modalities
Theme 2 will present top notch trends on novel bio-drug modalities by major biopharma players
Theme 9
New Biosimilars
Theme 9 will demonstrate current competitions in cost-effective Biosimilar development across the world.
Theme 3
Next Generation Antibody Therapies
Theme 3 will cover a vast variety of hot topics from emerging antibody discovery technologies to antibody engineering and bioanalysis
Theme 10
New Scientists
Theme 10 will cover current frontiers of innovative DDS for bio-drugs and difficult delivery biotherapies.
Theme 4
Next Generation Vaccines
Theme 4 will provide a global platform to discuss about the present and future developments and advances in vaccines R & D.
Theme 11
Japanese Biopharma Frontier
Theme 11 will help those who are interested in understanding Japanese research and market of up-to date breakthroughs in biopharmaceutical R & D.
Theme 5
New Biopharma Tech
Theme 5 will attract those exciting disruptive technologies, which have been applied in bio-drug R & D.
Theme 12
Biopharma Financing and Investment
Theme 12 aims to promote the linkage between social capital and pharmaceutical innovation and improve the innovation capability of biopharmaceutical industry.
Theme 6
New Discovery Chemistry
Theme 6 aims to support biopharma professionals to master Discovery chemistry on bio-molecular drugs.
Theme 13
Biological Therapy of Human Major Diseases
Theme 13 will bring the exchange of the most cutting edge preclinical and clinical data on the use of biotherapies in human major diseases between basic scientists and clinicians from academic, regulatory, and industrial experts.
Theme 7
New Bioprocessing
Theme 7 will focus on practical and fascinating intelligent manufacturing for challenging Biotherapies from IO drugs to gene, protein, antibodies and cell therapies.
Theme 14
Project Matchmaking Meeting
Theme 14 will build a professional, accurate and high-end docking, exchange and display platform for promoting achievements transformation and resource sharing.
Activity 1
Social Events, Gala-Dinner and Japanese Art Performance
The social activity will invite you to be with us for idea sharing, networking, friendship, fun and romance.
Activity 2
Tech-Tour & Lectures to Campus
Activity 2 will help our participants to enjoy the across cultural lecture tour in Tokyo and other cities in Japan.
Renowned Speakers of Past Events

Dr. Ei-ichi Negishi,
2010 Nobel Prize in Chemistry
H. C. Brown Distinguished Professor of Chemistry
Purdue University
Dr. Ada E. Yonath,
2009 Nobel Prize Laureate in Chemistry
Director & Professor
Weizmann Institute of Science
Dr. Arieh Warshel,
2010 Nobel Prize in Chemistry
Distinguished Professor
University of Southern California
Dr. Maode Lai,
Academician of Nationale Akademie der Wissenschafte
China Pharmaceutical University
Matthias von Herrath,
Vice President,
Novo Nordisk
Dr. Gilles Courtemanche,
Associate Director,
Antimicrobials Unit, BIOASTER,
Dr. Mingqiang Zhang,
Vice President Amgen BioPharmaceutical Co., Ltd.
Dr. Litao Zhang,
Vice President,
Bristol-Myers Squibb
Joseph Donahue,
Managing Director
Dr. Kenneth G. Faulkner,
Vice President,
PAREXEL Informatics
Dr. Daryl C. Drummond,
Senior Vice President & Head of Research
Merrimack Pharmaceuticals
Dr. Henrietta Ukwu,
Senior Vice President & Global Head, Global Quality & Global
Regulatory Affairs, Otsuka Pharmaceutica
Dr. Lucas P.J.J. Noldus,
Founder & CEO, Noldus Information Technology bv, the Netherlands
Michael Gamlen,
Chief Scientific Officer
Gamlen Tableting Ltd
Dr. Loui Madakamutil,
Senior Vice President
Nektar Therapeutics
Dr. Jan Hoflack,
Chief Scientific and Operational Officer,
Oncodesign SA
Dr. David C. Bunton,
Chief Executive Officer
REPROCELL Europe Ltd.,
Dr. Kurt Herrenknecht,
Founder & Managing Director
SciArcum Biotech Consulting
Dr. Hankoo Lee,
Honorary Chairman
Daehwa Pharmaceutical Co.
South Korea
Dr. Yoshinori Ikeura
Chief Executive Officer
Axcelead Drug Discovery Partners, Inc.
Zhuo Li,
General Manager
Nano Temper
Gregory L. Verdine,
Harvard University and Harvard Medical School
Dr. David A. Horne,
Vice Provost
Beckman Research Institute
Pavel Hobza,
Distinguish Chair
Academy of Sciences of the Czech Republic
Czech Republic
Exhibition and Poster

GSB-2022 provides an ideal platform to showcase your novel technologies and products in the Venetian Tokyo Resort Hotel. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at GSB-2022
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall


Exhibition Date:
Set-up date: May 10, 2022
Show dates: May 11-13, 2022
Place: Tokyo, Japan

© 2003-2022 All rights reserved by BIT Group Global Ltd.
Contact Us: Tel: 0086-411-84799606, Fax: 0086-411-84796897